2022 Revenues ($USD) : $9,785,315,000
2022 R&D spend : n/a
2022 Number of Employees : 17,300
Fiscal Year End : 12/31/2021
Company CEO : Edward Pesicka, president and CEO

Owens & Minor first opened in 1882 under the name Owens & Minor Drug Co. Now based in Mechanicsville, Virginia, the company started to grow beyond its pharmaceutical wholesaling background in 1981 and became a publicly-traded company in 1988.

Owens & Minor, through its subsidiary Halyard, was a big player in personal protective equipment during the COVID-19 pandemic. It distributed masks and N95 respirators to frontline workers and continued to make surgical gowns, drapes and packs, sterilization wraps, surgical accessories and equipment covers, exam gloves and other PPE. Its other two global product divisions — MediChoice and Medical Action Industries — make patient monitoring, respiratory, skin care, urology, wound care, IV start kits, procedure trays, mobility aids and more. Owens & Minor consistently ranks among the top 20 revenue earners in MDO's Big 100 rankings of the largest medical device companies.

In March 2022, the company closed its $1.6 billion purchase of Apria, a developer of home medical equipment for respiratory therapy, sleep apnea treatment, negative pressure wound therapy, and continuous glucose monitoring. Owens & Minor combined its Byram Healthcare business with Apria to create the new Patient Direct segment. That segment — along with the Products & Healthcare Services segment combining the global products, medical distribution and services businesses — replace the company’s two legacy segments. –DK and JH